Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer

被引：0
|
作者：
Park, J. Y. [1 ]
Jang, S. H. [1 ]
Kim, H. I. [1 ]
Kim, J. [1 ]
Park, S. [1 ]
Hwang, Y. I. [1 ]
Jung, K. [1 ]
机构：
[1] Hallym Univ, Sacred Heart Hosp, Pulm Allergy & Crit Care Med, Anyang, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Surgery; survival; advanced NSCLC;
D O I：
10.1016/j.jtho.2018.08.1642
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-82
引用
收藏
页码：S898 / S898
页数：1
相关论文
共 50 条
  • [1] Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
    Jang, Seung Hun
    Park, Sojung
    Lee, Chang Youl
    Park, Ji Young
    Kim, Joo-Hee
    Park, Sunghoon
    Hwang, Yong Il
    Jung, Ki-Suck
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] The role of surgery in the treatment of stage IIIB non-small cell lung cancer
    Grunenwald, Dominique H.
    EJC SUPPLEMENTS, 2007, 5 (05): : 263 - 267
  • [3] Guidelines on treatment of stage IIIB non-small cell lung cancer
    Jett, JR
    Scott, WJ
    Rivera, MP
    Sause, WT
    CHEST, 2003, 123 (01) : 221S - 225S
  • [4] Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    Collaud, Stephane
    Provost, Bastien
    Besse, Benjamin
    Fabre, Dominique
    Le Chevalier, Thierry
    Mercier, Olaf
    Mussot, Sacha
    Fadel, Elie
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1570 - 1574
  • [5] Should Surgery Be Part of the Multimodality Treatment for Stage IIIB Non-Small Cell Lung Cancer
    Collaud, Stephane
    Provost, Bastien
    Fabre, Dominique
    Mussot, Sacha
    Besse, Benjamin
    Mercier, Olaf
    Fadel, Elie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S576 - S576
  • [6] Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
    Pitz, CCM
    Maas, KW
    Van Swieten, HA
    de la Rivière, AB
    Hofman, P
    Schramel, FMNH
    ANNALS OF THORACIC SURGERY, 2002, 74 (01): : 164 - 169
  • [7] Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer
    Eberhardt, Wilfried
    Gauler, Thomas
    Poettgen, Christoph
    Krbek, Thomas
    Korfee, Soenke
    Stamatis, Georgios
    Stuschke, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : S35 - S36
  • [8] Survival outcome of chemotherapy in stage IIIA and IIIB non-small cell lung cancer
    Aly, A. S. E. S.
    Ellaithy, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S107 - S107
  • [9] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [10] Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Yumuk, P. F.
    Teomete, M.
    Dane, F.
    Cabuk, D.
    Basaran, G.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345